中文

VMD

₫13,550
+0.00% 2026-09-15 · Close
AI Composite Signal
5.7 / 10
Neutral — 5-signal composite
Mkt Cap
223.9B
₫223.9B
P/E
8.2
P/B
0.5
ROE
6.5%
ROA
2.4%
EPS
1.8K
Price Chart
What matters now

VMD (VMD) is a company in Vietnam's Health Care sector, listed on HOSE. The stock last traded at 13,550 VND, little changed on the session, giving a market capitalization of 223.9 billion VND.

On valuation, VMD trades at a price-to-earnings ratio of 8.2 and a price-to-book of 0.5. That is a discount to the Health Care sector average P/E of 18.9. Return on equity of 6.5% points to modest profitability relative to the company's equity base, below the sector average of 11.5%. Trailing earnings per share stand at 1,778 VND.

Aveluro tracks 8 news items mentioning VMD, where recent coverage skews negative (100% of articles). The most recent catalyst was a regulation change event — "VMD Stock Moved to Restricted Trading on HOSE From September 16, 2026". Aveluro's composite model rates VMD 5.7/10 (Neutral), blending news sentiment, price momentum, and fundamentals.

Comparable names in the Health Care sector include AGP, AMP and AMV.

Latest catalyst

VMD Stock Moved to Restricted Trading on HOSE From September 16, 2026

Recent Developments

Recent developments around VMD include 5 notable classified events. On Sep 11, 2026, a market event was reported: VMD of Y Dược phẩm Vimedimex will move from controlled to restricted trading on HOSE from September 16, 2026 under Decision 702/QĐ-SGDHCM, after continued breaches of information disclosure rules. On Aug 07, 2026, a market event was reported: HOSE has expanded its margin-ineligible list to 57 securities, including Vietnam Airlines (HVN), Duc Giang Chemicals (DGC), and newly listed DMX. On Jun 12, 2026, a leadership change was reported: Vimedimex Pharmaceutical (VMD) faces a leadership shake-up as a board member and three supervisory board members resign ahead of the 2026 Annual General Meeting scheduled for June 12. On May 26, 2026, a market event was reported: ITD was added to HOSE's margin-cut list after receiving a tax penalty for fiscal years 2022-2025, totaling VND 630.6 million. On Apr 20, 2026, a market event was reported: HoSE placed VNE, DTA, VMD, and SBV under warning status from April 24, primarily for delayed submission of audited 2025 financial reports or reports receiving qualified audit opinions.

The overall tone of recent coverage is negative, with 5 of 5 events carrying bearish sentiment.

AI Signal Breakdown
Bearish Neutral Bullish
5.7 / 10
Neutral
Sentiment
-1.00
Impact
0.70
Momentum
-0.22
Fundamentals
+0.50
Volume
1.00
Sentiment 30% · Impact 20% · Momentum 20% · Fundamentals 15% · Volume 15%
News Sentiment
8
Articles Analyzed
Negative 8
Recent News
Sep 11, 2026 Full Analysis Negative regulation change
VMD of Y Dược phẩm Vimedimex will move from controlled to restricted trading on HOSE from September 16, 2026 under Decision 702/QĐ-SGDHCM, after continued breaches of information disclosure rules. The stock already sits under warning status tied to a qualified audit opinion on its reviewed 2025 consolidated financial statements.
Aug 07, 2026 Full Analysis Negative regulation change
HOSE has expanded its margin-ineligible list to 57 securities, including Vietnam Airlines (HVN), Duc Giang Chemicals (DGC), and newly listed DMX. Investors cannot use leverage to buy these shares, potentially reducing liquidity and adding selling pressure in the short term.
Jun 12, 2026 Full Analysis Negative leadership change
Vimedimex Pharmaceutical (VMD) faces a leadership shake-up as a board member and three supervisory board members resign ahead of the 2026 Annual General Meeting scheduled for June 12. Separately, HoSE issued a reminder for late submission of Q1/2026 financial reports, raising governance concerns.
May 26, 2026 Full Analysis Negative regulation change
ITD was added to HOSE's margin-cut list after receiving a tax penalty for fiscal years 2022-2025, totaling VND 630.6 million. The list now includes 68 stocks, many under warning, control, or with negative profits, restricting leverage for investors.
Apr 20, 2026 Full Analysis Negative regulation change
HoSE placed VNE, DTA, VMD, and SBV under warning status from April 24, primarily for delayed submission of audited 2025 financial reports or reports receiving qualified audit opinions. VNE's warning stems from a 15-day delay, while VMD faces additional restrictions due to repeated disclosure violations.
Apr 20, 2026 Full Analysis Negative regulation change
HOSE has placed DRH Holdings (DRH), Tổng CTCP Xây dựng Điện Việt Nam (VNE), CTCP Đệ Tam (DTA), CTCP Y Dược phẩm Vimedimex (VMD), and CTCP Siam Brothers Việt Nam (SBV) under warning or control status from April 24, 2026, primarily for delayed submission of audited 2025 financial reports or reports with qualified audit opinions. This regulatory action highlights ongoing compliance issues and could affect trading liquidity and investor sentiment for these HOSE-listed stocks.
Apr 17, 2026 Full Analysis Negative regulation change
Vimedimex (VMD) received a formal reprimand from HoSE on April 15, 2026, for failing to disclose required explanations for its audited 2025 financial statements by the deadline. The statements show strong profit growth but contain audit qualifications over VND 198.9B in blocked deposits and VND 1,578B in long-term receivables from former leaders, raising governance and asset-quality concerns for investors.
Related Stocks — Health Care
Stock Analysis

By Aveluro Research Team · Editorial policy · Caveat: Not investment advice. · How Aveluro computed this

Information provided for educational purposes only. Past performance does not guarantee future results. Data sourced from public Vietnamese market feeds.

Last updated: 2026-09-15T17:29:55Z.